PRIA Logo™
119-hr-5187119th CongressWALLET

To establish in the Department of Defense a program to support the expansion of domestic bioindustrial manufacturing capacity.

Sponsored By: Representative Khanna, Ro [D-CA-17]

Introduced

Summary

This bill would expand domestic bioindustrial manufacturing capacity by creating a Department of Defense Bioindustrial Commercialization Program that awards competitive funds to private entities to establish, upgrade, or retool U.S. facilities producing critical biomanufactured products. It would require an initial plan to Congress within 90 days, annual award reports, and would sunset after 10 years unless the President extends it.

Show full summary
  • Private bioindustrial companies: Eligible private entities could compete for DoD awards to set up, upgrade, or retool U.S. bioindustrial facilities and to fund related business or technical plans.
  • Department of Defense and national security: Award selection must weigh a technology’s ability to protect critical supply chains and to meet capabilities needed by the next generation of warfighters. Recipients must report progress toward agreements to supply critical biomanufactured products to the Department of Defense.
  • Communities and regional capacity: The Secretary must consider whether facilities can be repurposed, produce a range of products, are near input sources or existing hubs, and whether awards support wide geographic distribution across the United States.

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

Analyzed Economic Effects

1 provisions identified: 1 benefits, 0 costs, 0 mixed.

Defense awards for bio manufacturing plants

If enacted, the Defense Department could start a new program within one year. It would give competitive awards to private companies to build, upgrade, or retool U.S. bio manufacturing plants for critical products, and to develop related business or technical plans. Selection would weigh supply chain resilience, warfighter needs, repurposing potential, location, and proximity to inputs. Recipients would file regular progress reports; the Secretary would send an initial plan to Congress within 90 days and annual reports starting within one year. The program would end after 10 years unless the President extends it for national economic and security needs; awards would depend on future funding from Congress.

Sponsors & CoSponsors

Sponsor

Khanna, Ro [D-CA-17]

CA • D

Cosponsors

  • Rep. Garamendi, John [D-CA-8]

    CA • D

    Sponsored 9/8/2025

  • Rep. Davis, Donald G. [D-NC-1]

    NC • D

    Sponsored 9/8/2025

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation